ESR1 and cancer: Novel findings regarding altered prevalence in ER+/HER2− tumors according to BMI of somatic mutation of the TBX3 gene, which is involved in a complicated and extensive gene regulatory network57, were made but require further investigation to infer their implications, especially in the cancer-obesity cascade.